Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAP 098 BV Study
PACTR202607878828981Completed
- Sponsor
- Gates Foundation
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of metronidazole in bacterial vaginosis (BV), sponsored by Gates Foundation. Started Sep 2024; status: completed.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on PACTR202607878828981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607878828981.